← All companiesIImmunityBio, Inc.
IBRX - CIK 0001326110
ImmunityBio, Inc. revenue by year
ImmunityBio, Inc. (IBRX) reported revenue of $113.29M for fiscal year 2025, as filed in its audited annual report with the SEC.
IBRX annual revenue
IBRX revenue 2013-2025
| Fiscal year | Revenue | Change |
|---|
| FY 2025 | $113.29M | +668.3% |
| FY 2024 | $14.74M | +2270.6% |
| FY 2023 | $622.00K | +159.2% |
| FY 2022 | $240.00K | -74.3% |
| FY 2021 | $934.00K | +54.4% |
| FY 2020 | $605.00K | -72.5% |
| FY 2019 | $2.20M | +4585.1% |
| FY 2018 | $47.00K | +4.4% |
| FY 2017 |
Revenue of similar companies
Frequently asked questions
How much revenue does ImmunityBio, Inc. make?
ImmunityBio, Inc. (IBRX) reported revenue of $113.29M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has ImmunityBio, Inc.'s revenue changed over time?
Between fiscal 2013 and fiscal 2025, ImmunityBio, Inc.'s revenue grew from $600.00K to $113.29M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.